Iradimed Corporation (NASDAQ:IRMD - Get Free Report) shares traded up 8% during mid-day trading on Thursday . The company traded as high as $55.56 and last traded at $55.77. 12,296 shares changed hands during trading, a decline of 71% from the average session volume of 42,537 shares. The stock had previously closed at $51.66.
Analyst Ratings Changes
A number of analysts recently issued reports on the company. Roth Mkm reissued a "buy" rating and set a $72.00 price objective (up previously from $60.00) on shares of Iradimed in a report on Friday, February 14th. Wall Street Zen raised Iradimed from a "buy" rating to a "strong-buy" rating in a report on Tuesday, May 6th.
Read Our Latest Report on IRMD
Iradimed Trading Down 0.1%
The firm has a fifty day simple moving average of $52.40 and a two-hundred day simple moving average of $54.41. The stock has a market cap of $738.74 million, a PE ratio of 38.73 and a beta of 0.91.
Iradimed Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were issued a $0.17 dividend. The ex-dividend date was Tuesday, May 20th. This represents a $0.68 annualized dividend and a dividend yield of 1.17%. Iradimed's payout ratio is currently 43.87%.
Hedge Funds Weigh In On Iradimed
Several institutional investors and hedge funds have recently bought and sold shares of the stock. MetLife Investment Management LLC grew its position in shares of Iradimed by 11.4% in the 4th quarter. MetLife Investment Management LLC now owns 4,845 shares of the medical equipment provider's stock worth $266,000 after buying an additional 494 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Iradimed by 11.2% in the 4th quarter. Principal Financial Group Inc. now owns 5,440 shares of the medical equipment provider's stock worth $299,000 after buying an additional 546 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Iradimed by 21.8% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 16,306 shares of the medical equipment provider's stock worth $897,000 after buying an additional 2,921 shares during the last quarter. Proficio Capital Partners LLC bought a new stake in shares of Iradimed in the 4th quarter worth approximately $926,000. Finally, Avantax Advisory Services Inc. bought a new stake in shares of Iradimed in the 4th quarter worth approximately $217,000. 92.34% of the stock is currently owned by institutional investors.
Iradimed Company Profile
(
Get Free Report)
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Read More
Before you consider Iradimed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Iradimed wasn't on the list.
While Iradimed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
